Product Information
CEFUROXIME AXETIL 250 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2798 per EA under NDC 67877021560. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877021560
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFUROXIME AXETILApproval Type
Generic (ANDA)
FDA Application
ANDA065496FDA Approved
6/7/2010
TE Code
AB
On Market Since
12/1/2010
Pharmacological Classes
Price Statistics
The NADAC for CEFUROXIME AXETIL 250 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 27.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2798 per EA |
|---|---|
| All-time high | $1.7095 (May 14, 2014) |
| All-time low | $0.2260 (Nov 20, 2024) |
| 52-week high | $0.2977 |
| 52-week low | $0.2798 |
| Median price | $0.4670 |
| Average price | $0.6302 |
| Largest weekly change | +350.4% (Apr 23, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefuroxime axetil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFUROXIME AXETIL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CEFUROXIME AXETIL 250 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.2798 per EA (NDC 67877021560), effective Sep 30, 2026.
How has the price of CEFUROXIME AXETIL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CEFUROXIME AXETIL 250 MG TAB has declined 27.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFUROXIME AXETIL 250 MG TAB?
Since Nov 28, 2013, the NADAC for CEFUROXIME AXETIL 250 MG TAB has ranged from a low of $0.2260 (Nov 20, 2024) to a high of $1.7095 (May 14, 2014), with a median of $0.4670 per EA.
Are there cheaper alternatives to CEFUROXIME AXETIL 250 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFUROXIME AXETIL 250 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFUROXIME AXETIL 250 MG TAB?
CEFUROXIME AXETIL 250 MG TAB (NDC 67877021560) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.